Today's biopharmaceutical landscape demands a fundamental rethinking of outsourcing approaches that embrace collaboration, flexibility, and teams willing to meet halfway.
Kerri McCaul-Claus
Advertisement
Kerri McCaul-Claus is Vice President and Head of FSP Biometrics at Parexel.
Articles by Kerri McCaul-Claus
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
2
HHS Launches SURPASS Program and Three Complementary Initiatives to Transform Clinical Trial Design and Infrastructure
3
Where AI Leads in Trial Design—and Where Humans Still Need To
4
What an AI-Informed Approach Means for How Sponsors Think About Risk
5